𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in the Adjuvant Treatment of HER2-Overexpressing Breast Cancer with the Anti-HER2 Antibody Trastuzumab

✍ Scribed by Chris Schwab; Joyce A. O'Shaughnessy

Book ID
114412594
Publisher
CIG Media Group, LP.
Year
2005
Tongue
English
Weight
467 KB
Volume
6
Category
Article
ISSN
1526-8209

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Targeting endothelin A receptor enhances
Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells
✍ Jeanett FischgrΓ€be; Martin GΓΆtte; Katharina Michels; Ludwig Kiesel; Pia WΓΌlfing πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev